Aptevo Theraoeutics has sold their recombinant factor IX product IXINITY® to Canada-based Medexus Pharmaceuticals. IXINITY®, which first received approval from the U.S. Food and Drug Administration (FDA) in 2015, is currently indicated for the…
On the eve of Bleeding Disorders Awareness Month, more than 400 members of the bleeding disorders community put on their red ties and traveled to Washington DC to meet with their Members of Congress and share how federal legislation and funding…
Background:
Current available factor replacement therapy (FRT) for von Willebrand Disease (vWD) contains FVIII. Thromboembolic events (TEE) are a small but serious risk in patients with elevated FVIII levels as a result of…
The Centers for Disease Control and Prevention (CDC) is responding to the rapidly evolving situation of the outbreak of respiratory disease (COVID-19) caused by a novel coronavirus (SARS-CoV-2). Though this was first detected in Wuhan City, Hubei…
The World Health Organization (WHO) has declared a Public Health Emergency of International Concern (PHEIC) in response to the 2019-nCoV (novel coronavirus) outbreak. This is a serious health situation and we extend our sympathies to people in the…
Takeda announced the recall of two lots of VONVENDI vonWillebrand factor (recombinant) 1,300 I.U. vials on February 25, 2020. HFA and NHF recognize that recalls can be very unsettling for many in the bleeding disorders community.
We are in…
Late yesterday (February 25, 2020), Takeda announced a pharmacy-level recall of two lots of VONVENDI von Willebrand factor (recombinant) 1,300 IU vials. Takeda’s announcement stated that
“Although both lots met all acceptance criteria, Takeda is…
The Partners in Bleeding Disorders Education Program has announced the launch a new version of “Understanding Hemophilia,” a six-part online learning activity for clinicians who practice at federally recognized U.S. hemophilia treatment centers (…
For over three decades I treated families with bleeding disorders, working towards finding better treatments for patients and preventing complications of their disorders through education, advocacy, and research. My work was most gratifying when I…
The National Hemophilia Foundation (NHF) is very pleased to announce that the recipient of the 2020 Physical Therapy Excellence Fellowship is Nancy Durben, PT. Nancy practices physical therapy with the Hemophilia Center at Oregon Health &…